| | |
Per Note
|
| |
Total
|
| ||||||
Public offering price
|
| | | $ | 25.00 | | | | | $ | 175,000,000 | | |
Underwriting discount
|
| | | $ | 0.75 | | | | | $ | 5,250,000 | | |
Proceeds to us, before expenses
|
| | | $ | 24.25 | | | | | $ | 169,750,000 | | |
| | |
Page
|
| |||
| | | | S-1 | | | |
| | | | S-2 | | | |
| | | | S-4 | | | |
| | | | S-6 | | | |
| | | | S-10 | | | |
| | | | S-15 | | | |
| | | | S-16 | | | |
| | | | S-17 | | | |
| | | | S-29 | | | |
| | | | S-31 | | | |
| | | | S-37 | | | |
| | | | S-38 | | | |
| | | | S-39 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 10 | | | |
| | | | 15 | | | |
| | | | 17 | | | |
| | | | 19 | | | |
| | | | 22 | | | |
| | | | 23 | | | |
| | | | 24 | | | |
| | | | 28 | | | |
| | | | 32 | | | |
| | | | 65 | | | |
| | | | 66 | | | |
| | | | 67 | | | |
| | | | 68 | | | |
| | | | 69 | | |
| | |
As of September 30, 2020
|
| |||||||||
| | |
Actual
|
| |
As adjusted(1)
|
| ||||||
| | |
(In thousands, except share
and per share data) |
| |||||||||
Cash and cash equivalents
|
| | | $ | 149,847 | | | | | $ | 268,596 | | |
Debt:
|
| | | | | | | | | | | | |
5.75% senior notes due 2026 offered hereby(1)
|
| | | $ | — | | | | | $ | 169,300 | | |
Secured borrowings
|
| | | | 1,176,621 | | | | | | 1,176,621 | | |
Securitized debt obligations of consolidated variable interest entities, net
|
| | | | 2,059,114 | | | | | | 2,059,114 | | |
Convertible notes, net
|
| | | | 111,855 | | | | | | 111,855 | | |
Senior secured notes, net
|
| | | | 179,572 | | | | | | 179,572 | | |
Corporate debt, net
|
| | | | 150,658 | | | | | | 101,001 | | |
Guaranteed loan financing
|
| | | | 421,183 | | | | | | 421,183 | | |
Liabilities for loans eligible for repurchase from Ginnie Mae
|
| | | | 237,542 | | | | | | 237,542 | | |
Derivative instruments
|
| | | | 7,774 | | | | | | 7,774 | | |
Dividends payable
|
| | | | 16,934 | | | | | | 16,934 | | |
Accounts payable and other accrued liabilities
|
| | | | 132,087 | | | | | | 131,536(2) | | |
Total Debt
|
| | | | 4,493,340 | | | | | | 4,612,982 | | |
Stockholders’ Equity:
|
| | | | | | | | | | | | |
Common stock, par value $0.0001 per share; 500,000,000 shares authorized; 54,175,648 shares issued and outstanding
|
| | | | 5 | | | | | | 5 | | |
Additional paid-in capital
|
| | | | 846,960 | | | | | | 846,960 | | |
Retained earnings
|
| | | | (31,779) | | | | | | (32,115)(3) | | |
Accumulated other comprehensive loss
|
| | | | (9,916) | | | | | | (9,916) | | |
Total Common Stockholders’ Equity
|
| | | | 805,270 | | | | | | 804,934 | | |
Non-controlling interests
|
| | | | 18,900 | | | | | | 18,893(3) | | |
Total Stockholders’ Equity
|
| | | | 824,170 | | | | | | 823,827 | | |
Total Capitalization
|
| | | $ | 5,317,510 | | | | | $ | 5,436,259 | | |
Underwriters
|
| |
Principal
Amount of Notes |
| |||
Keefe, Bruyette & Woods, Inc.
|
| | | $ | 58,333,334 | | |
Morgan Stanley & Co. LLC
|
| | | $ | 58,333,333 | | |
Piper Sandler & Co.
|
| | | $ | 58,333,333 | | |
Total | | | | $ | 175,000,000 | | |
Underwriters
|
| |
Per
Note |
| |
Without
Option |
| |
With
Option |
| |||||||||
Public Offering Price
|
| | | $ | 25.00 | | | | | $ | 175,000,000 | | | | | $ | 201,250,000 | | |
Underwriting Discount
|
| | | $ | 0.75 | | | | | $ | 5,250,000 | | | | | $ | 6,037,500 | | |
Proceeds to Us, Before Expenses
|
| | | $ | 24.25 | | | | | $ | 169,750,000 | | | | | $ | 195,212,500 | | |
Document
|
| |
Period
|
|
| | Year ended December 31, 2019 | | |
| | Year ended December 31, 2019 | | |
| | Quarter ended March 31, 2020 | | |
| | Quarter ended June 30, 2020 | | |
| | Quarter ended September 30, 2020 | | |
| | January 7, 2020 | | |
| | April 30, 2020 | | |
| | June 24, 2020 | | |
| | July 20, 2020 | | |
| | December 7, 2020 | | |
| | December 8, 2020 | | |
| | December 10, 2020 | | |
| | May 14, 2020 | | |
Description of our common stock contained in our Registration Statement on Form 8-A (“Form 8-A”) as updated by Exhibit 4.11 to the Annual Report on Form 10-K for the year ended December 31, 2019 (“Exhibit 4.11”) (File No. 001-35808) | | | February 6, 2013 (Form 8-A) | |
| | | March 12, 2020 (Exhibit 4.11) | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 10 | | | |
| | | | 15 | | | |
| | | | 17 | | | |
| | | | 19 | | | |
| | | | 22 | | | |
| | | | 23 | | | |
| | | | 24 | | | |
| | | | 28 | | | |
| | | | 32 | | | |
| | | | 65 | | | |
| | | | 66 | | | |
| | | | 67 | | | |
| | | | 68 | | | |
| | | | 69 | | |
Document
|
| |
Period
|
|
Annual Report on Form 10-K (File No. 001-35808) | | | Year ended December 31, 2019 | |
Annual Report on Form 10-K/A (File No. 001-35808) | | | Year ended December 31, 2019 | |
Quarterly Report on Form 10-Q (File No. 001-35808) | | | Quarter ended March 31, 2020 | |
Current Report on Form 8-K (File No. 001-35808) | | | January 7, 2020 | |
Form 12b-25 (File No. 001-35808) | | | April 30, 2020 | |
Current Report on Form 8-K (File No. 001-35808) | | | June 24, 2020 | |
Current Report on Form 8-K (File No. 001-35808) | | | July 20, 2020 | |
Definitive Proxy Statement on Schedule 14A (File No. 001-35808) | | | May 14, 2020 | |
Description of our common stock contained in our Registration Statement on Form 8-A (“Form 8-A”) as updated by Exhibit 4.11 to the Annual Report on Form 10-K for the year ended December 31, 2019 (“Exhibit 4.11”) (File No. 001-35808) | | |
February 6, 2013 (Form 8-A) March 12, 2020 (Exhibit 4.11) |
|